89Zr-Panitumumab

panitumumab labeled with zirconium-89 · Stanford University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 89Zr-Panitumumab, covering 2023-05-19 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: 89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC [Phase 2]